Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mblue Labs is a biotechnology company focused on the development of anti-aging and skin health solutions utilizing the antioxidant properties of Methylene Blue. Founded by Dr. Kan Cao, a leading researcher in the field of aging and progeria, the company leverages its proprietary platform to create products that target mitochondrial health and cellular longevity. Their flagship commercial line, Bluelene, incorporates Methylene Blue to stimulate collagen and elastin production while protecting skin from oxidative stress. Beyond skincare, the company explores the therapeutic potential of its technology in treating rare aging diseases and enhancing wound recovery. Mblue Labs operates as a spin-off from the University of Maryland, bridging academic research with consumer health applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mblue Labs.